266 related articles for article (PubMed ID: 7041131)
61. Methods to detect and quantitate complement activation.
Cooper NR; Nemerow GR; Mayes JT
Springer Semin Immunopathol; 1983; 6(2-3):195-212. PubMed ID: 6195745
[No Abstract] [Full Text] [Related]
62. Structure and activation of C1: current concepts.
Colomb MG; Arlaud GJ; Villiers CL
Complement; 1984; 1(2):69-80. PubMed ID: 6100485
[No Abstract] [Full Text] [Related]
63. Autoantibodies against C1q in systemic lupus erythematosus.
Siegert CE; Breedveld FC; Daha MR
Behring Inst Mitt; 1993 Dec; (93):279-86. PubMed ID: 8172577
[No Abstract] [Full Text] [Related]
64. Failure of oligosaccharide MOPC-104E IgM complexes to bind C1q and to activate C1.
Weiner EM
Biochem Int; 1987 Jul; 15(1):163-8. PubMed ID: 3502595
[TBL] [Abstract][Full Text] [Related]
65. Further evidence for dilution-dependent dissociation of C1q in human serum.
Hosoi S; Borsos T
Complement Inflamm; 1989; 6(4):259-69. PubMed ID: 2788553
[TBL] [Abstract][Full Text] [Related]
66. The biochemistry of complement.
Porter RR; Reid KB
Nature; 1978 Oct; 275(5682):699-704. PubMed ID: 703835
[TBL] [Abstract][Full Text] [Related]
67. [Immune and nonimmune complement activation].
Porcel-Pérez JM; Ordi-Ros J
Rev Clin Esp; 1996 Mar; 196 Spec No():3-6. PubMed ID: 9206805
[No Abstract] [Full Text] [Related]
68. Synergistic complement lysis by monoclonal antibodies to the human leukocyte common antigen requires both the classical and alternative pathways.
Bindon CI; Hale G; Hughes-Jones N; Gorick B; Waldmann H
Mol Immunol; 1987 Jun; 24(6):587-94. PubMed ID: 2958690
[TBL] [Abstract][Full Text] [Related]
69. C1 activation by immunoglobulin and immunoglobulin antibodies.
Hughes-Jones NC; Feinstein A; Richardson NE; Gorick BD; Howard JC
Biochem Soc Trans; 1984 Oct; 12(5):738-9. PubMed ID: 6333999
[No Abstract] [Full Text] [Related]
70. Activation of the first component of complement, C1: comparison of the effect of sixteen different enzymes on serum C1.
Heinz HP; Loos M
Immunobiology; 1983 Aug; 165(2):175-85. PubMed ID: 6195090
[TBL] [Abstract][Full Text] [Related]
71. [Binding and activation of the first component of human complement on artificial matrices].
Kozlov LV; Sizoĭ MN; Zinchenko AA; Ivanov AE; Zubov VP
Bioorg Khim; 1984 Dec; 10(12):1629-38. PubMed ID: 6529444
[TBL] [Abstract][Full Text] [Related]
72. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
[TBL] [Abstract][Full Text] [Related]
73. Activation of the early components of the classical complement pathway under physiologic conditions.
Ziccardi RJ
J Immunol; 1981 May; 126(5):1769-73. PubMed ID: 7217665
[No Abstract] [Full Text] [Related]
74. [Perioperative changes of complement (C1q, C3, C4) with cardiopulmonary bypass].
Wang YT; Xu JX; Zhu YL
Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Apr; 16(2):86-8, 126-7. PubMed ID: 3264237
[No Abstract] [Full Text] [Related]
75. [Mechanism of complement activity].
Chenchikova EP
Zh Mikrobiol Epidemiol Immunobiol; 1978 Jul; (7):21-31. PubMed ID: 308752
[No Abstract] [Full Text] [Related]
76. Spontaneous activation of reconstituted and serum C1 and the role of C1-inhibitor.
Schumaker VN; Tseng Y; Poon PH; Bianchino AC; Zavodszky P
Behring Inst Mitt; 1989 Jul; (84):102-10. PubMed ID: 2803179
[TBL] [Abstract][Full Text] [Related]
77. Antibody-independent killing of gram-negative bacteria via the classical pathway of complement.
Loos M; Clas F
Immunol Lett; 1987 Feb; 14(3):203-8. PubMed ID: 3032781
[TBL] [Abstract][Full Text] [Related]
78. IgG binding to cytoskeletal intermediate filaments activates the complement cascade.
Hansson GK; Lagerstedt E; Bengtsson A; Heideman M
Exp Cell Res; 1987 Jun; 170(2):338-50. PubMed ID: 3496230
[TBL] [Abstract][Full Text] [Related]
79. Mechanism of complement activation after coronary artery occlusion: evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1q in vivo.
Rossen RD; Michael LH; Kagiyama A; Savage HE; Hanson G; Reisberg MA; Moake JN; Kim SH; Self D; Weakley S
Circ Res; 1988 Mar; 62(3):572-84. PubMed ID: 3257722
[TBL] [Abstract][Full Text] [Related]
80. [Cellular receptors for complement components: repertory and functions].
Sobel A; Blanc C; Cattaneo A; Moisy M; Lopez-Trascasa M
Ann Immunol (Paris); 1982; 133C(2):199-205. PubMed ID: 7051951
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
